Login / Signup
Bhupendra V Shravage
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 6
Top Topics
Ischemia Reperfusion Injury
Oxide Nanoparticles
Breast Cancer Cells
Heat Shock
Top Venues
Nanomedicine (London, England)
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Neha Kulkarni-Dwivedi
,
Pratikshkumar R Patel
,
Bhupendra V Shravage
,
Rinku D Umrani
,
Kishore M Paknikar
,
Sachin Hanmant Jadhav
Hyperthermia and doxorubicin release by Fol-LSMO nanoparticles induce apoptosis and autophagy in breast cancer cells.
Nanomedicine (London, England)
17 (25) (2023)
Neha Kulkarni-Dwivedi
,
Pratikshkumar R Patel
,
Bhupendra V Shravage
,
Rinku D Umrani
,
Kishore M Paknikar
,
Sachin Hanmant Jadhav
Hyperthermia and doxorubicin release by Fol-LSMO nanoparticles induce apoptosis and autophagy in breast cancer cells.
Nanomedicine (London, England)
(2023)
Neha Kulkarni-Dwivedi
,
Pratikshkumar R Patel
,
Bhupendra V Shravage
,
Rinku D Umrani
,
Kishore M Paknikar
,
Sachin Hanmant Jadhav
Hyperthermia and doxorubicin release by Fol-LSMO nanoparticles induce apoptosis and autophagy in breast cancer cells.
Nanomedicine (London, England)
17 (25) (2023)
Neha Kulkarni-Dwivedi
,
Pratikshkumar R Patel
,
Bhupendra V Shravage
,
Rinku D Umrani
,
Kishore M Paknikar
,
Sachin Hanmant Jadhav
Hyperthermia and doxorubicin release by Fol-LSMO nanoparticles induce apoptosis and autophagy in breast cancer cells.
Nanomedicine (London, England)
17 (25) (2023)
Neha Kulkarni-Dwivedi
,
Pratikshkumar R Patel
,
Bhupendra V Shravage
,
Rinku D Umrani
,
Kishore M Paknikar
,
Sachin Hanmant Jadhav
Hyperthermia and doxorubicin release by Fol-LSMO nanoparticles induce apoptosis and autophagy in breast cancer cells.
Nanomedicine (London, England)
17 (25) (2023)
Neha Kulkarni-Dwivedi
,
Pratikshkumar R Patel
,
Bhupendra V Shravage
,
Rinku D Umrani
,
Kishore M Paknikar
,
Sachin Hanmant Jadhav
Hyperthermia and doxorubicin release by Fol-LSMO nanoparticles induce apoptosis and autophagy in breast cancer cells.
Nanomedicine (London, England)
17 (25) (2023)